Angiogenesis, a crucial step in the growth and
metastasis of
cancers, is initiated with vasodilation mediated by
nitric oxide (NO). The pro-inflammatory
cytokine, tumour
necrosis factor-alpha (
TNF-alpha), is a mediator of
nitric oxide synthesis. We analyzed the effect of
allyl isothiocyanate (
AITC) and
phenyl isothiocyanate (PITC) on serum NO as well as
TNF-alpha level during angiogenesis. In vivo antiangiogenic activity was studied using B16F-10
melanoma cell-induced capillary formation in C57BL/6 mice. Intraperitoneal administration of
AITC and PITC at a concentration of 25 microg/dose/animal significantly inhibited tumour-directed capillary formation. Treatment of
AITC and PITC significantly downregulated serum NO as well as
TNF-alpha level in angiogenesis-induced animals compared to untreated control animals. The in vitro antiangiogenic study, using rat aortic ring assay, showed that both
AITC and PITC at non-toxic concentrations inhibited the production of proangiogenic factors from B16F-10
melanoma cells which was evident with the inhibition of microvessel outgrowth from aortic rings. Both
AITC and PITC significantly inhibited
sodium nitroprusside as well as
TNF-alpha-induced microvessel outgrowth from rat aortic ring. Administration of
AITC and PITC also significantly reduced NO and
TNF-alpha production by LPS-stimulated macrophages both in vivo as well as in vitro. Bio-assay using serum of angiogenesis-induced animals and supernatant from LPS-stimulated macrophages clearly confirmed the downregulatory action of
AITC and PITC on
TNF-alpha production. These results clearly demonstrated that
AITC and PITC inhibited tumour-specific angiogenesis by downregulating NO and
TNF-alpha production.